MFIMFI
Mesirow Financial Investment Management - Fixed Income’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-85,990
| Closed | -$13.3M | – | 140 |
|
|
2021
Q4 | $13.3M | Sell |
85,990
-1,120
| -1% | -$173K | 1.46% | 7 |
|
|
2021
Q3 | $12.1M | Buy |
87,110
+68,865
| +377% | +$9.59M | 1.41% | 11 |
|
|
2021
Q2 | $2.39M | Buy |
18,245
+4,260
| +30% | +$559K | 0.27% | 92 |
|
|
2021
Q1 | $2.13M | Buy |
+13,985
| New | +$2.13M | 0.25% | 104 |
|
|
2019
Q1 | – | Sell |
-62,671
| Closed | -$8.5M | – | 124 |
|
|
2018
Q4 | $8.5M | Buy |
62,671
+16,454
| +36% | +$2.23M | 1.14% | 50 |
|
|
2018
Q3 | $12.7M | Sell |
46,217
-31,030
| -40% | -$8.52M | 1.15% | 45 |
|
|
2018
Q2 | $16M | Sell |
77,247
-7,405
| -9% | -$1.53M | 1.47% | 14 |
|
|
2018
Q1 | $14M | Sell |
84,652
-22,235
| -21% | -$3.67M | 1.37% | 24 |
|
|
2017
Q4 | $14.6M | Sell |
106,887
-34,739
| -25% | -$4.76M | 1.03% | 68 |
|
|
2017
Q3 | $19.3M | Sell |
141,626
-31,665
| -18% | -$4.31M | 1.27% | 33 |
|
|
2017
Q2 | $21M | Sell |
173,291
-1,165
| -0.7% | -$141K | 1.41% | 23 |
|
|
2017
Q1 | $18.5M | Sell |
174,456
-3,315
| -2% | -$351K | 1.23% | 35 |
|
|
2016
Q4 | $18.1M | Sell |
177,771
-29,725
| -14% | -$3.02M | 1.11% | 50 |
|
|
2016
Q3 | $21.2M | Buy |
207,496
+32,165
| +18% | +$3.28M | 1.24% | 35 |
|
|
2016
Q2 | $20.9M | Buy |
+175,331
| New | +$20.9M | 1.22% | 39 |
|